Skip to content
healthcare.dev

BUPROPION HYDROCHLORIDE (SR)

NDC 69097-877, Bupropion Hydrochloride, tablet, extended release, from Cipla USA Inc.,.

Product NDC
69097-877
Status
Listed
Labeler
Cipla USA Inc.,
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206674
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-877 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE100 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
69097-877-026909708770230 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-02)
69097-877-036909708770360 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-03)
69097-877-0769097087707100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-07)
69097-877-1269097087712500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d2c209b-248e-4e26-9cde-fe0abe4428c1

Use it

Look up 69097-877 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-877 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-877. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.